Entresto (sacubitril/valsartan)

pCPA File Number: 20915
Negotiation Status:
Concluded with an LOI
Indication(s):
Heart failure, NYHA class II or III
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
SR0447-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: